BIOMARIN PHARMACEUTICAL INC（BMRN）内部人交易：高管与董事近期交易
过去 18 个月，共有 19 位内部人为 BIOMARIN PHARMACEUTICAL INC（BMRN）报告了 69 笔 Form 4 交易（最近一笔 2026-10-01）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-01 | Friberg Gregory R | EVP, Chief R&D Officer | 卖出 | 4,086 | $245,160 |
| 2026-09-14 | Plenge Robert M | 董事 | 买入 | 6,140 | $0 |
| 2026-09-03 | Davis George Eric | EVP, Chief Legal Officer | 卖出 | 17,557 | $1.2M |
| 2026-06-04 | Ho Maykin | 董事 | 买入 | 7,490 | $0 |
| 2026-06-04 | CLARK IAN T | 董事 | 买入 | 7,490 | $0 |
| 2026-06-04 | HOMBACH ROBERT J. | 董事 | 买入 | 7,490 | $0 |
| 2026-06-04 | Enyedy Mark J | 董事 | 买入 | 7,490 | $0 |
| 2026-06-04 | Bodem Barbara W. | 董事 | 买入 | 7,490 | $0 |
| 2026-06-04 | Walbert Timothy P | 董事 | 买入 | 7,490 | $0 |
| 2026-06-04 | ANDERSON ELIZABETH M | 董事 | 买入 | 7,490 | $0 |
| 2026-06-04 | Countouriotis Athena | 董事 | 买入 | 7,490 | $0 |
| 2026-06-04 | Dere Willard H | 董事 | 买入 | 7,490 | $0 |
| 2026-05-21 | Hubbard Cristin | EVP, Chief Commercial Officer | 卖出 | 2,318 | $116,364 |
| 2026-05-11 | Friberg Gregory R | EVP, Chief R&D Officer | 卖出 | 3,281 | $176,682 |
| 2026-03-19 | Mueller Brian | EVP, Chief Financial Officer | 卖出 | 2,117 | $118,658 |
| 2026-03-19 | Guyer Charles Greg | EVP, Chief Technical Officer | 卖出 | 1,693 | $94,893 |
| 2026-03-19 | Davis George Eric | EVP, Chief Legal Officer | 卖出 | 1,273 | $71,352 |
| 2026-03-19 | Hardy Alexander | Chief Executive Officer | 卖出 | 4,252 | $238,325 |
| 2026-03-18 | Hubbard Cristin | EVP, Chief Commercial Officer | 卖出 | 1,245 | $69,782 |
| 2026-03-18 | Hubbard Cristin | EVP, Chief Commercial Officer | 买入 | 15,410 | $0 |
| 2026-03-18 | Friberg Gregory R | EVP, Chief R&D Officer | 买入 | 19,150 | $0 |
| 2026-03-18 | Friberg Gregory R | EVP, Chief R&D Officer | 卖出 | 1,629 | $91,305 |
| 2026-03-17 | Mueller Brian | EVP, Chief Financial Officer | 卖出 | 9,945 | $581,882 |
| 2026-03-17 | Mueller Brian | EVP, Chief Financial Officer | 买入 | 18,740 | $0 |
| 2026-03-17 | Guyer Charles Greg | EVP, Chief Technical Officer | 卖出 | 9,109 | $532,968 |
来源：SEC Form 4 申报文件 · 截至 2026-10-01